Putin likely did not directly order Navalny’s killing, U.S. intelligence agencies conclude
Sources said the assessment doesn’t absolve Putin of ultimate responsibility for Navalny’s fate, only that Putin likely didn’t call for his killing at the time.
GOP Rep. Bill Posey won’t seek re-election
On Friday, the Republican congressman said, “circumstances beyond my control now require me to suspend my re-election campaign,” and endorsed a successor.
Snap shares rocket 28% after company reports unexpected profit, better-than-expected revenue
Snap shares soared on Friday after the company provided uplifting results, suggesting its online ad business is getting back on track.
The Fed will be the main event in the week ahead that includes a jobs report, more tech earnings
The Federal Reserve’s latest policy announcement will be the main event for investors in the week ahead.
Federal regulator finds Tesla Autopilot has ‘critical safety gap’ linked to hundreds of collisions
Federal authorities say a “critical safety gap” in Tesla’s Autopilot system contributed to at least 467 collisions, 13 resulting in fatalities.
Intel used to dominate the U.S. chip industry. Now it’s struggling to stay relevant
Intel has missed most of the significant technology transitions over the past 15-plus years, losing its standing in the chip industry along the way.
Biden says he would be ‘happy to debate’ Trump
The president made the remark Friday in an interview with radio host Howard Stern amid Trump’s calls for a debate.
Ashley Biden detailed ‘pain’ from diary theft, urged prison for thief in letter to judge
Ashley Biden, the daughter of President Joe Biden, asked a judge to sentence the woman who stole her diary to prison, an unsealed letter shows.
Key Fed inflation measure rose 2.8% in March from a year ago, more than expected
The core personal consumption expenditures price index was expected to increase 2.7% from a year ago in March, according to the Dow Jones consensus estimate.
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
The agency greenlighted the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
